Home | Contact Us | Search | Site Map
About Us Technology Products R&D Partners Investors Media Careers Hidden
Crucell
MAbstract® Technology



  PER.C6® Technology
  Vaccine Technology
  Protein Technology
  PER.C6® Technology
  STAR® Technology
  MAbstract® Technology
  Description
  Applications
  Partnering Opportunities

Key Strengths
  • MAbstract® technology uses a subtraction method of selection, which is not available when generating human antibodies with other technologies, for example in transgenic mice.

 

  • MAbstract® technology does not have the inherent limitation on antibody specificity that is seen in transgenic mice.

 

  • MAbstract® technology has been used to isolate antibodies for numerous disease applications. Selected antibody specificities can be directly reformatted into antibodies for production using PER.C6® technology.

 

  • Fully human antibodies have an excellent safety profile, which is a main advantage over other antibody formats, including humanized and chimeric.
  E-mail this page   Print this page

    Home  |  Contact Us  |  Search  |  Site Map  |  
MoveNext - Latus © Crucell 2006 | Disclaimer